Decision curve analyses demonstrating the net benefit associated with the use of the Briganti 2012 nomogram for 248 patients [6]. The net benefit can be interpreted as the proportion of all patients who have lymph node metastases and are recommended for surgical excision of pelvic lymph nodes.